Diabetes

The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Aerial shot of neighborhood | Image credit: trekandphoto – stock.adobe.com
How Neighborhood Social Needs Drive Diabetes Care Disparities

October 18th 2024

Unmet social needs in certain neighborhoods contribute to disparities in diabetes care, leading to greater reliance on emergency services, fewer preventive measures, and higher rates of complications.

Lifestyle and dietary changes have proven benefits for patients with diabetes, sometimes eliminating the need for their medications | image credit: Africa Studio - stock.adobe.com
The Off-Ramp: Novel Diabetes Reversal Program Bolsters Support of Nonpharmacological Disease Management

October 8th 2024

Diabetes | Image credit: Sherry Young – stock.adobe.com
What the Diabetes Health Economy Looks Like in 2024

October 1st 2024

Senate. | Image Credit: Corgarashu - stock.adobe.com
Semaglutide Accessibility and Affordability Addressed at Senate Committee Hearing

September 24th 2024

Gavel and money | Image credit: BillionPhotos.com - stock.adobe.com
FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs

September 20th 2024

More News

Site Logo
June 14th 2017

WCHN Launches New Study to Investigate Link Between Diabetes and Pancreatic Cancer

Alison Rodriguez
On June 14, 2017, Western Connecticut Health Network (WCHN) announced its launch of a new study that will research the connection between pancreatic cancer and new-onset diabetes. This $2.7 million study will span 3 years and aims to discover a method to detect pancreatic cancer while it can still be cured.
Site Logo
June 14th 2017

Cigna Leads $50M Round of Financing for Omada Health

Mary Caffrey
The collaboration between a digital behavioral health provider and an insurer comes as CMS admits challenges setting up the Medicare Diabetes Prevention Program.
Site Logo
June 13th 2017

Sanofi Presents New Results for Insulin GLP-1 Combo Soliqua

Mary Caffrey
Studies presented at the 77th Scientific Sessions of the American Diabetes Association show that the combination therapy helps patients with the highest glycated hemoglobin levels gain control quickly.
Site Logo
June 13th 2017

DEVOTE: Tresiba Offers Same CV Safety, 40% Drop in Hypoglycemia vs Lantus

Mary Caffrey
The study's lead author said that complications from cardiovascular disease remain an unmet clinical challenge in type 2 diabetes.
Dr Bruce Neal Discusses Canagliflozin's Potential for Heart Failure Prevention
June 13th 2017

Dr Bruce Neal Discusses Canagliflozin's Potential for Heart Failure Prevention

The CANVAS study’s outcomes were “a positive first step” in proving that canagliflozin can be used for the primary prevention of heart failure in patients with diabetes, but more evidence is needed, according to the study’s lead author, Bruce Neal, MB, ChB, PhD, of the George Institute for Global Health at UNSW Sydney, who presented the findings at the 77th Scientific Sessions of the American Diabetes Association’s in San Diego, California.
Dr Eda Cengiz Explains Artificial Pancreas Systems' Implications for Patients and Clinicians
June 13th 2017

Dr Eda Cengiz Explains Artificial Pancreas Systems' Implications for Patients and Clinicians

Hybrid closed-loop insulin delivery systems, also referred to as an artificial pancreas, can help improve the management of diabetes while researchers seek a cure, as well as provide reassurance for patients and their families, according to Eda Cengiz, MD, MHS, FAAP, associate professor of pediatrics at Yale School of Medicine.
Site Logo
June 12th 2017

CGM "Debate" Finds Benefits, Barriers to Uptake for Type 2 Diabetes

Mary Caffrey
A light-hearted format for the discussion at the 77th Scientific Sessions of the American Diabetes Association still brought out the seriousness of the issue: too many with type 2 diabetes have poor glycemic control, and another medication may not be the answer.
Site Logo
June 12th 2017

CANVAS Finds Lower Risk of CV Events for Invokana

Mary Caffrey
The long-awaited results from CANVAS show a reduced risk of cardiovascular events. The study's lead author said clinicians should balance the significant benefits of the drug against the potential harms for a small number of patients with known risks.
Site Logo
June 12th 2017

Phase 3 Results Show Lower A1C for Ertugliflozin, Combined With Metformin and With Sitagliptin

Mary Caffrey
Results presented at the 77th Scientific Sessions of the American Diabetes Association are for combinations with ertugliflozin, an investigational SGLT2 inhibitor before FDA.
Site Logo
June 11th 2017

Heart Failure Needs More Attention in Diabetes Drug Trials, Expert Says

Mary Caffrey Angelia Szwed
At a symposium at the 77th Scientific Sessions of the American Diabetes Association, experts suggested that the relationship between heart failure and diabetes is finally getting the attention it deserves.
Dr William Polonsky on the Promising Potential of Continuous Glucose Monitoring
June 11th 2017

Dr William Polonsky on the Promising Potential of Continuous Glucose Monitoring

Continuous glucose monitoring has the potential to revolutionize diabetes care for patients with type 2 diabetes, whether they are on insulin therapy or not, but the technology must be accompanied by stronger support from clinicians in order to be most successful, explained William Polonsky, PhD, CDE, president of the Behavioral Diabetes Institute and associate clinical professor at University of California, San Diego.
Nina Brown-Ashford Outlines Development and Next Steps of CMS Diabetes Prevention Program
June 11th 2017

Nina Brown-Ashford Outlines Development and Next Steps of CMS Diabetes Prevention Program

The Diabetes Prevention Program (DPP) has demonstrated that it can improve the quality of care for Medicare beneficiaries with diabetes while saving or maintaining costs, explained Nina Brown-Ashford, MPH, CHES, deputy group director at the CMS Innovation Center. Next, CMS will finalize the DPP’s expansion in another round of rulemaking.
Site Logo
June 11th 2017

Medicare's Diabetes Prevention Program Is Coming, but CMMI Has Work to Do

Mary Caffrey
No one questions the long-term savings that the Diabetes Prevention Program will bring to Medicare, but getting it off the ground will require several steps that have never been done before, including a new payment model.
Dr Neal Kaufman Weighs Advantages of Digital and In-Person Diabetes Management Programs
June 10th 2017

Dr Neal Kaufman Weighs Advantages of Digital and In-Person Diabetes Management Programs

Diabetes management programs can be delivered digitally or in a traditional in-person setting, but there are benefits and drawbacks to each, explained Neal Kaufman, MD, founder and chief medical officer of Canary Health.
Dr Robert Gabbay Highlights 3 Exciting Areas of Developing Diabetes Technology
June 10th 2017

Dr Robert Gabbay Highlights 3 Exciting Areas of Developing Diabetes Technology

There are a number of exciting technological advances that could change diabetes care as we know it, such as improved continuous glucose monitors and convenient decision support tools, said Robert Gabbay, MD, PhD, chief medical officer of the Joslin Diabetes Center.
Site Logo
June 9th 2017

Study Mentions Concerns of Diabetic Ketoacidosis When Starting SGLT2 Inhibitors

Christina Mattina
Prior data had indicated that sodium-glucose cotransporter 2 (SGLT2) inhibitors could be linked to diabetic ketoacidosis, a serious complication of diabetes.
This Week in Managed Care: June 9, 2017
June 9th 2017

This Week in Managed Care: June 9, 2017

This week, the top managed care stories included findings that some cancers are being diagnosed earlier after people gain coverage under the Affordable Care Act; a new poll gauged Americans' views on Medicaid; and JDRF launched a new campaign to meet the needs of people with type 1 diabetes.
Site Logo
June 8th 2017

Overweight Children Are Left Out of Friendships, Study Finds

Mary Caffrey
Being isolated due to being overweight can have long-term health consequences, and the study's lead author said reducing stigma should be part of anti-bullying efforts.
Site Logo
June 8th 2017

Heavy Alcohol Use Leads to Greater Muscle Loss After Menopause, Study Finds

Mary Caffrey
While alcohol is known to limit skeletal muscle growth, few studies have looked at the relationship between sarcopenia and problem drinking.
Site Logo
June 7th 2017

Study Finds Increased PCSK9 in Youth With Type 1 Diabetes

Mary Caffrey
The enzyme that affects the body's ability to process LDL cholesterol was found to be correlated with A1C levels. A symposium on the topic will be part of this weekend's 77th Scientific Sessions of the American Diabetes Association.
Site Logo
June 7th 2017

WHO Essential Medicines List Adds New Drugs, Categorizes Antibiotics

Christina Mattina
When the World Health Organization (WHO) updates its Essential Medicines List every 2 years, observers anticipate the addition of some new drugs or alternate indications. The 20th edition, released Tuesday, also includes a more drastic change by categorizing antibiotics.
Site Logo
June 6th 2017

Waist-to-Height Ratio Beats BMI for Finding Obesity, Study Says

Mary Caffrey
The study said the alternative to BMI offers a better way to measure visceral fat, which poses a greater cardiovascular threat.
Site Logo
June 5th 2017

Americans Buying Less Sodium in Packaged Foods, but Opportunities for Improvement Remain

Christina Mattina
Amid recent efforts to curtail sodium levels in packaged foods to prevent hypertension and heart disease, the amount of sodium in foods and beverages purchased by US households has decreased, according to a new study. However, most Americans are still buying sodium-dense foods, indicating the need for intensified initiatives to lower sodium intake.
Site Logo
June 1st 2017

Childhood Obesity Raises Risk of Arterial Damage in Adulthood, Study Finds

Mary Caffrey
Researchers from the United Kingdom combed studies to figure out which of several indicators, such as body mass index or waist circumference, were predictors of future cardiac events or health conditions, like hypertension or prediabetes.
Site Logo
May 31st 2017

Novo Nordisk Asks FDA to Update Tresiba Label on Hypoglycemia

Mary Caffrey
While regulators long ago saw enough cardiovascular safety data to approve insulin degludec, full trial results will be presented June 12 at the American Diabetes Association Scientific Sessions in San Diego.
The Importance of Real-World Data in Type 2 Diabetes
May 30th 2017

The Importance of Real-World Data in Type 2 Diabetes

Understanding the DUAL VII Findings in Type 2 Diabetes
May 30th 2017

Understanding the DUAL VII Findings in Type 2 Diabetes

Impact of Cardiovascular Data in Type 2 Diabetes
May 30th 2017

Impact of Cardiovascular Data in Type 2 Diabetes

Access to Therapeutic Combinations in Type 2 Diabetes
May 30th 2017

Access to Therapeutic Combinations in Type 2 Diabetes

Hypoglycemia: An Unrecognized Complication in Diabetes
May 30th 2017

Hypoglycemia: An Unrecognized Complication in Diabetes

<1
...
363738394041424344
...
97>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo